In Reply: Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety.
暂无分享，去创建一个
[1] Nidan Qiao. Letter: Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety. , 2019, Neurosurgery.
[2] M. Chicoine,et al. Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety. , 2018, Neurosurgery.
[3] S. Julious,et al. The statistical interpretation of pilot trials: should significance thresholds be reconsidered? , 2014, BMC Medical Research Methodology.
[4] D. Kelly,et al. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts. , 2013, World neurosurgery.
[5] Jacqueline M. Regan,et al. Selective Use of Peri-Operative Steroids in Pituitary Tumor Surgery: Escape from Dogma , 2013, Front. Endocrinol..
[6] Nigel Stallard,et al. Optimal sample sizes for phase II clinical trials and pilot studies , 2012, Statistics in medicine.
[7] D. Schoenfeld,et al. Statistical considerations for pilot studies. , 1980, International journal of radiation oncology, biology, physics.